Skip to main content
Journal cover image

Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial.

Publication ,  Journal Article
Weissler, EH; Clare, RM; Lokhnygina, Y; Buse, JB; Goodman, SG; Katona, B; Iqbal, N; Pagidipati, NJ; Sattar, N; Holman, RR; Hernandez, AF ...
Published in: Diabet Med
October 2021

AIMS: Although models exist to predict amputation among people with type 2 diabetes with foot ulceration or infection, we aimed to develop a prediction model for a broader range of major adverse limb events (MALE)-including gangrene, revascularization and amputation-among individuals with type 2 diabetes. METHODS: In a post-hoc analysis of data from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL) trial, we compared participants who experienced MALE with those who did not. A multivariable model was constructed and translated into a risk score. RESULTS: Among the 14,752 participants with type 2 diabetes in EXSCEL, 3.6% experienced MALE. Characteristics associated with increased risk of MALE were peripheral artery disease (PAD) (HRadj 4.83, 95% CI: 3.94-5.92), prior foot ulcer (HRadj 2.16, 95% CI: 1.63-2.87), prior amputation (HRadj 2.00, 95% CI: 1.53-2.64), current smoking (HRadj 2.00, 95% CI: 1.54-2.61), insulin use (HRadj 1.86, 95% CI: 1.52-2.27), coronary artery disease (HRadj 1.67, 95% CI: 1.38-2.03) and male sex (HRadj 1.64, 95% CI: 1.31-2.06). Cerebrovascular disease, former smoking, age, glycated haemoglobin, race and neuropathy were also associated significantly with MALE after adjustment. A risk score ranging from 6 to 96 points was constructed, with a C-statistic of 0.822 (95% CI: 0.803-0.841). CONCLUSIONS: The majority of MALE occurred among participants with PAD, but participants without a history of PAD also experienced MALE. A risk score with good performance was generated. Although it requires validation in an external dataset, this risk score may be valuable in identifying patients requiring more intensive care and closer follow-up.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Diabet Med

DOI

EISSN

1464-5491

Publication Date

October 2021

Volume

38

Issue

10

Start / End Page

e14552

Location

England

Related Subject Headings

  • Vascular Surgical Procedures
  • Sex Factors
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Peripheral Arterial Disease
  • Middle Aged
  • Male
  • Hypoglycemic Agents
  • Humans
  • Glycated Hemoglobin
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Weissler, E. H., Clare, R. M., Lokhnygina, Y., Buse, J. B., Goodman, S. G., Katona, B., … Jones, W. S. (2021). Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial. Diabet Med, 38(10), e14552. https://doi.org/10.1111/dme.14552
Weissler, E Hope, Robert M. Clare, Yuliya Lokhnygina, John B. Buse, Shaun G. Goodman, Brian Katona, Nayyar Iqbal, et al. “Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial.Diabet Med 38, no. 10 (October 2021): e14552. https://doi.org/10.1111/dme.14552.
Weissler EH, Clare RM, Lokhnygina Y, Buse JB, Goodman SG, Katona B, et al. Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial. Diabet Med. 2021 Oct;38(10):e14552.
Weissler, E. Hope, et al. “Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial.Diabet Med, vol. 38, no. 10, Oct. 2021, p. e14552. Pubmed, doi:10.1111/dme.14552.
Weissler EH, Clare RM, Lokhnygina Y, Buse JB, Goodman SG, Katona B, Iqbal N, Pagidipati NJ, Sattar N, Holman RR, Hernandez AF, Mentz RJ, Patel MR, Jones WS. Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial. Diabet Med. 2021 Oct;38(10):e14552.
Journal cover image

Published In

Diabet Med

DOI

EISSN

1464-5491

Publication Date

October 2021

Volume

38

Issue

10

Start / End Page

e14552

Location

England

Related Subject Headings

  • Vascular Surgical Procedures
  • Sex Factors
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Peripheral Arterial Disease
  • Middle Aged
  • Male
  • Hypoglycemic Agents
  • Humans
  • Glycated Hemoglobin